Aurisco Pharmaceutical Co.,Ltd. (605116.SS)
CNY 20.8
(-0.48%)
CNY 20.8
(-0.48%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.57 Billion CNY | 26.65% |
| 2022 | 2.03 Billion CNY | 18.09% |
| 2021 | 1.72 Billion CNY | 12.28% |
| 2020 | 1.53 Billion CNY | 39.35% |
| 2019 | 1.1 Billion CNY | 19.5% |
| 2018 | 920.69 Million CNY | 12.78% |
| 2017 | 816.38 Million CNY | 4.42% |
| 2016 | 781.82 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.68 Billion CNY | 4.37% |
| 2024 Q3 | 3.69 Billion CNY | 28.63% |
| 2024 Q2 | 2.86 Billion CNY | 6.79% |
| 2023 Q3 | 2.36 Billion CNY | 10.28% |
| 2023 FY | 2.57 Billion CNY | 26.65% |
| 2023 Q2 | 2.14 Billion CNY | 1.73% |
| 2023 Q1 | 2.1 Billion CNY | 3.77% |
| 2023 Q4 | 2.57 Billion CNY | 8.79% |
| 2022 Q4 | 2.03 Billion CNY | 9.45% |
| 2022 Q3 | 1.85 Billion CNY | 4.17% |
| 2022 Q2 | 1.78 Billion CNY | 3.01% |
| 2022 Q1 | 1.73 Billion CNY | 0.55% |
| 2022 FY | 2.03 Billion CNY | 18.09% |
| 2021 Q3 | 1.62 Billion CNY | 4.02% |
| 2021 Q1 | 1.55 Billion CNY | 1.74% |
| 2021 Q4 | 1.72 Billion CNY | 5.65% |
| 2021 FY | 1.72 Billion CNY | 12.28% |
| 2021 Q2 | 1.56 Billion CNY | 0.42% |
| 2020 Q4 | 1.53 Billion CNY | 1.95% |
| 2020 FY | 1.53 Billion CNY | 39.35% |
| 2020 Q3 | 1.5 Billion CNY | 28.95% |
| 2020 Q2 | 1.16 Billion CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q2 | 981.78 Million CNY | 0.0% |
| 2019 Q4 | 1.1 Billion CNY | 0.0% |
| 2019 FY | 1.1 Billion CNY | 19.5% |
| 2018 FY | 920.69 Million CNY | 12.78% |
| 2017 FY | 816.38 Million CNY | 4.42% |
| 2016 FY | 781.82 Million CNY | 0.0% |